TNF A liquid formulation of anti-TNF alpha antibody
The present invention relates to a liquid formulation of an anti-TNF alpha antibody, and specifically, to a liquid formulation of adalimumab. The anti-TNF alpha antibody, specifically a liquid formulation of adalimumab of the present invention reduces the generation of byproducts of adalimumab durin...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; kor |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | SO RA YUN JINEON SO YOUN KYUNG KO |
| description | The present invention relates to a liquid formulation of an anti-TNF alpha antibody, and specifically, to a liquid formulation of adalimumab. The anti-TNF alpha antibody, specifically a liquid formulation of adalimumab of the present invention reduces the generation of byproducts of adalimumab during the storage period, thereby enabling long term storage. The liquid formulation of an anti-TNF alpha antibody contains the anti-TNF alpha antibody, a stabilizer, a surfactant, and arginine.
본 발명은 항-TNF 알파 항체, 구체적으로 아달리무맙의 액상 제제에 관한 것이다. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20180106974A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20180106974A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20180106974A3</originalsourceid><addsrcrecordid>eNrjZDAO8XNTcFTIySwszUxRSMsvyi3NSSzJzM9TyE9TSMwrydQFKUjMKchIBHOT8lMqeRhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJvHeQkYGhhYGhgZmluYmjMXGqACEOLDk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>TNF A liquid formulation of anti-TNF alpha antibody</title><source>esp@cenet</source><creator>SO RA YUN ; JINEON SO ; YOUN KYUNG KO</creator><creatorcontrib>SO RA YUN ; JINEON SO ; YOUN KYUNG KO</creatorcontrib><description>The present invention relates to a liquid formulation of an anti-TNF alpha antibody, and specifically, to a liquid formulation of adalimumab. The anti-TNF alpha antibody, specifically a liquid formulation of adalimumab of the present invention reduces the generation of byproducts of adalimumab during the storage period, thereby enabling long term storage. The liquid formulation of an anti-TNF alpha antibody contains the anti-TNF alpha antibody, a stabilizer, a surfactant, and arginine.
본 발명은 항-TNF 알파 항체, 구체적으로 아달리무맙의 액상 제제에 관한 것이다.</description><language>eng ; kor</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181001&DB=EPODOC&CC=KR&NR=20180106974A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76418</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181001&DB=EPODOC&CC=KR&NR=20180106974A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SO RA YUN</creatorcontrib><creatorcontrib>JINEON SO</creatorcontrib><creatorcontrib>YOUN KYUNG KO</creatorcontrib><title>TNF A liquid formulation of anti-TNF alpha antibody</title><description>The present invention relates to a liquid formulation of an anti-TNF alpha antibody, and specifically, to a liquid formulation of adalimumab. The anti-TNF alpha antibody, specifically a liquid formulation of adalimumab of the present invention reduces the generation of byproducts of adalimumab during the storage period, thereby enabling long term storage. The liquid formulation of an anti-TNF alpha antibody contains the anti-TNF alpha antibody, a stabilizer, a surfactant, and arginine.
본 발명은 항-TNF 알파 항체, 구체적으로 아달리무맙의 액상 제제에 관한 것이다.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAO8XNTcFTIySwszUxRSMsvyi3NSSzJzM9TyE9TSMwrydQFKUjMKchIBHOT8lMqeRhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJvHeQkYGhhYGhgZmluYmjMXGqACEOLDk</recordid><startdate>20181001</startdate><enddate>20181001</enddate><creator>SO RA YUN</creator><creator>JINEON SO</creator><creator>YOUN KYUNG KO</creator><scope>EVB</scope></search><sort><creationdate>20181001</creationdate><title>TNF A liquid formulation of anti-TNF alpha antibody</title><author>SO RA YUN ; JINEON SO ; YOUN KYUNG KO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20180106974A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; kor</language><creationdate>2018</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>SO RA YUN</creatorcontrib><creatorcontrib>JINEON SO</creatorcontrib><creatorcontrib>YOUN KYUNG KO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SO RA YUN</au><au>JINEON SO</au><au>YOUN KYUNG KO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>TNF A liquid formulation of anti-TNF alpha antibody</title><date>2018-10-01</date><risdate>2018</risdate><abstract>The present invention relates to a liquid formulation of an anti-TNF alpha antibody, and specifically, to a liquid formulation of adalimumab. The anti-TNF alpha antibody, specifically a liquid formulation of adalimumab of the present invention reduces the generation of byproducts of adalimumab during the storage period, thereby enabling long term storage. The liquid formulation of an anti-TNF alpha antibody contains the anti-TNF alpha antibody, a stabilizer, a surfactant, and arginine.
본 발명은 항-TNF 알파 항체, 구체적으로 아달리무맙의 액상 제제에 관한 것이다.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; kor |
| recordid | cdi_epo_espacenet_KR20180106974A |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | TNF A liquid formulation of anti-TNF alpha antibody |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T21%3A16%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SO%20RA%20YUN&rft.date=2018-10-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20180106974A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |